The doctor will ask about symptoms and health past. A physical exam will be done. The diagnosis is often made based on how the skin looks. Tests may be done to rule out other problems or to look for an infection.
Treatment can help to ease itching and redness. It may also reduce the number of flare ups. The medical team can also help to find what may be causing more irritation.
Scratching the skin can make symptoms worse and damage skin. Damaged skin will increase the risk of infection. Treatment can help to ease itchiness and protect the skin. Treatment steps may include:
Proper skin care may decrease injury to the area and allow the skin to heal. Steps to ease stress on skin include:
Avoid hot or long baths or showers.
Use mild, unscented bar soap or non-soap cleanser.
Do not scrub area. Air-dry or gently pat is better to dry skin.
Gentle moisturizers should be used after a shower when skin is still damp.
Treat skin infections right away.
Medicine may be needed to ease symptoms. Examples include:
Prescription creams and ointments. They can ease flare up and irritation of skin.
Prescription or over-the-counter antihistamines to help prevent itching.
Antibiotics to treat infection. It may be given as a cream or pill.
Pills to reduce inflammation of the skin.
Monoclonal antibody shots to reduce inflammation.
Light therapy may be tried if other care is not helpful. This may include:
Treatment with ultraviolet light
Psoralen, a medicine used to make skin more sensitive to light therapy
There are no steps to help reduce the risk of eczema.
Atopic dermatitis. National Institute of Arthritis and Musculoskeletal and Skin Diseases website. Available at: https://www.niams.nih.gov/health-topics/atopic-dermatitis. Updated July 2016. Accessed October 30, 2019.
Eczema and atopic dermatitis. Family Doctor—American Academy of Family Physicians website. Available at: https://familydoctor.org/condition/eczema-and-atopic-dermatitis. Updated June 2017. Accessed October 30, 2019.
7/14/2017 DynaMed Systematic Literature Surveillancehttp://www.dynamed.com/topics/dmp~AN~T115212/Atopic-dermatitis: Blauvelt A, deBruin-Weller M, et al. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and cocomitant topical corticosteroids (LIBERTY AND CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet. 2017;389(10086):2287-2303.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.